-transparent.png){kind=logo}
Multiple drug resistance (MDR) is a major problem of current chemotherapy. Establishment of multiple drug resistant cell lines in culture and isolation of P-glycoprotein-coding MDR genes have promoted understanding of the molecular mechanisms underlying drug resistance in tumors. Another gene, MRP, has been recently isolated from a multiple drug resistant cell line which did not express P-glycoprotein. Both genes have DNA sequence homology for each other and have been identified as members of ATP binding cassette (ABC) transporter superfamily. This review refers to recent progress in MDR and MRP study, and focuses on involvement of these two drug-resistance-related genes in acquiring drug resistance and their physiological functions.
M Wada, and
S Hasegawa, and
K Kohno, and
M Kuwano
March 1997,
Anales de medicina interna (Madrid, Spain : 1984),
M Wada, and
S Hasegawa, and
K Kohno, and
M Kuwano
February 2004,
Bioorganic & medicinal chemistry letters,
M Wada, and
S Hasegawa, and
K Kohno, and
M Kuwano
May 1991,
British journal of cancer,
M Wada, and
S Hasegawa, and
K Kohno, and
M Kuwano
January 1993,
Cytotechnology,
M Wada, and
S Hasegawa, and
K Kohno, and
M Kuwano
June 1991,
Haematologica,
M Wada, and
S Hasegawa, and
K Kohno, and
M Kuwano
January 1999,
Annals of oncology : official journal of the European Society for Medical Oncology,
M Wada, and
S Hasegawa, and
K Kohno, and
M Kuwano
January 2003,
La Clinica terapeutica,
M Wada, and
S Hasegawa, and
K Kohno, and
M Kuwano
December 1999,
La Revue du praticien,
M Wada, and
S Hasegawa, and
K Kohno, and
M Kuwano
January 2002,
Current medicinal chemistry,
M Wada, and
S Hasegawa, and
K Kohno, and
M Kuwano
January 1999,
Revista espanola de medicina nuclear,
